HarP: The EADC-ADNI harmonized protocol for manual hippocampal segmentation. A standard of reference from a global working group

Alzheimer's and Dementia

Volumn 11, Issue 2, 2015, Pages 107-110

  Frisoni, Giovanni B ^a,b   Jack, Clifford R ^c  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; TRACER;

ALZHEIMER DISEASE; AUTOPSY; BRAIN ATROPHY; CONCURRENT VALIDITY; DATA BASE; DELPHI STUDY; DISEASE COURSE; EARLY DIAGNOSIS; HARMONIZED HIPPOCAMPAL PROTOCOL; HIPPOCAMPUS; HUMAN; MACHINE LEARNING; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; SCIENTIFIC LITERATURE; ANATOMY AND HISTOLOGY; IMAGE PROCESSING; INTERNATIONAL COOPERATION; ORGAN SIZE; PATHOLOGY; PROCEDURES; THREE DIMENSIONAL IMAGING;

ALZHEIMER DISEASE; HIPPOCAMPUS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; INTERNATIONALITY; NEUROIMAGING; ORGAN SIZE;

EID: 84933524560     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2014.05.1761     Document Type: Editorial

References (8)

1. Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, et al. Research criteria for the diagnosis of Alzheimer's disease: Revising the NINCDS-ADRDA criteria. Lancet Neurol 2007; 6:734-46.
2. Galluzzi S, Geroldi C, Ghidoni R, Paghera B, Amicucci G, Bonetti M, et al. The new Alzheimer's criteria in a naturalistic series of patients with mild cognitive impairment. J Neurol 2010;257:2004-14.
3. Frisoni GB, Prestia A, Zanetti O, Galluzzi S, Romano M, Cotelli M, et al. Markers of Alzheimer's disease in a population attending a memory clinic. Alzheimers Dement 2009;5:307-17.
4. Bouwman FH, Schoonenboom SN, van der Flier WM, van Elk EJ, Kok A, Barkhof F, et al. CSF biomarkers and medial temporal lobe atrophy predict dementia in mild cognitive impairment. Neurobiol Aging 2007;28:1070-4.
5. Frisoni GB, Jack CR. Harmonization of magnetic resonance-based manual hippocampal segmentation: A mandatory step for wide clinical use. Alzheimers Dement 2011;7:171-4.
6. Jack CR, Barkhof F, Bernstein MA, Cantillon M, Cole PE, DeCarli C, et al. Steps to standardization and validation of hippocampal volumetry as a biomarker in clinical trials and diagnostic criterion for Alzheimer's disease. Alzheimers Dement 2011;7:474-85.
7. Boccardi M, Ganzola R, Bocchetta M, Pievani M, Redolfi A, Bartzokis G, et al. Survey of protocols for the manual segmentation of the hippocampus: preparatory steps towards a joint EADCADNI harmonized protocol. J Alzheimers Dis 2011;26(Suppl 3):61-75.
8. Committee for Medicinal Products for Human Use (CHMP). Qualification opinion of low hippocampal volume (atrophy) by MRI for use in clinical trials for regulatory purpose in pre-dementia stage of Alzheimer's disease. EMA/CHMP/SAWP/809208/2011. 17 November 2011.